Peter A Pinto

Author PubWeight™ 153.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 2013 4.64
2 Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 2011 4.01
3 Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. Radiology 2010 3.12
4 Robotic partial nephrectomy for complex renal tumors: surgical technique. Eur Urol 2007 3.07
5 Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol 2013 2.81
6 Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol 2013 2.62
7 Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol 2012 2.55
8 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. J Nucl Med 2012 2.42
9 Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 2010 2.38
10 Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology 2013 2.35
11 D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol 2011 2.10
12 UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet 2010 2.06
13 Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer 2013 1.97
14 Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 2007 1.86
15 Molecular diagnosis and therapy of kidney cancer. Annu Rev Med 2010 1.82
16 Imaging techniques for prostate cancer: implications for focal therapy. Nat Rev Urol 2009 1.76
17 Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes. J Urol 2010 1.74
18 Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease. J Am Coll Surg 2010 1.70
19 Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup. J Urol 2010 1.67
20 Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics. Clin Cancer Res 2007 1.64
21 Concomitant surgery with laparoscopic live donor nephrectomy. Am J Transplant 2003 1.62
22 Management of recurrent urethral fistulas after hypospadias repair. Urology 2003 1.61
23 Comprehensive microRNA Profiling of Prostate Cancer. J Cancer 2013 1.53
24 Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla. BJU Int 2012 1.51
25 Renal cell carcinoma with metastases to the gallbladder: four cases from the National Cancer Institute (NCI) and review of the literature. Urol Oncol 2011 1.48
26 Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol 2012 1.45
27 Laparoscopic partial nephrectomy: effect of warm ischemia on serum creatinine. J Urol 2004 1.44
28 Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes. J Urol 2007 1.43
29 Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int 2012 1.42
30 A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds. Rev Sci Instrum 2009 1.42
31 Feasibility and outcomes of repeat partial nephrectomy. J Urol 2008 1.41
32 Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med 2012 1.34
33 Robotic partial nephrectomy for renal hilar tumors: a multi-institutional analysis. J Urol 2008 1.33
34 Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer 2009 1.32
35 Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology 2012 1.28
36 Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology. J Magn Reson Imaging 2013 1.27
37 Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples. Nat Protoc 2009 1.27
38 Documenting the location of prostate biopsies with image fusion. BJU Int 2011 1.23
39 Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies. BJU Int 2014 1.22
40 Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience. J Urol 2009 1.21
41 Magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI-based moulds. BJU Int 2013 1.19
42 Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm. J Urol 2010 1.18
43 Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies. BJU Int 2014 1.18
44 An MRI-compatible robotic system with hybrid tracking for MRI-guided prostate intervention. IEEE Trans Biomed Eng 2011 1.14
45 Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12. Cancer Res 2009 1.12
46 The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome. Eur J Endocrinol 2007 1.11
47 Initial experience with robot assisted partial nephrectomy for multiple renal masses. J Urol 2009 1.11
48 Telerounding and patient satisfaction after surgery. J Am Coll Surg 2004 1.08
49 Partial adrenalectomy: underused first line therapy for small adrenal tumors. J Urol 2010 1.07
50 The clinical implications of the genetics of renal cell carcinoma. Urol Oncol 2009 1.03
51 Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup. J Urol 2012 1.03
52 Extraosseous (extramedullary) plasmacytoma of the adrenal gland. Arch Pathol Lab Med 2004 1.02
53 The role of MRI in active surveillance for prostate cancer. Curr Urol Rep 2015 1.01
54 Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis. Radiology 2013 0.99
55 Mechanisms of disease: the role of heat-shock protein 90 in genitourinary malignancy. Nat Clin Pract Urol 2006 0.98
56 Robot-assisted laparoscopic partial nephrectomy for tumors greater than 4 cm and high nephrometry score: feasibility, renal functional, and oncological outcomes with minimum 1 year follow-up. Urol Oncol 2011 0.97
57 Genetic basis of kidney cancer: a model for developing molecular-targeted therapies. BJU Int 2007 0.97
58 Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging. Med Phys 2012 0.96
59 Laparoscopic radical versus partial nephrectomy: assessment of complications. J Urol 2003 0.96
60 Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer. Cancer Immunol Immunother 2013 0.95
61 Management of von Hippel-Lindau-associated kidney cancer. Nat Clin Pract Urol 2005 0.95
62 Complications of abdominal urologic laparoscopy: longitudinal five-year analysis. Urology 2004 0.95
63 The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel. BJU Int 2013 0.94
64 Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit. J Urol 2010 0.93
65 Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project. BJU Int 2014 0.93
66 Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer. Nat Clin Pract Urol 2007 0.93
67 Robot-assisted laparoscopic partial adrenalectomy: initial experience. Urology 2010 0.93
68 Comparison of magnetic resonance imaging and ultrasound (MRI-US) fusion-guided prostate biopsies obtained from axial and sagittal approaches. BJU Int 2014 0.92
69 Influence of hypoxia induced by minimally invasive prostatectomy on gene expression: implications for biomarker analysis. Am J Transl Res 2010 0.91
70 Recent advances in image-guided targeted prostate biopsy. Abdom Imaging 2015 0.91
71 Identification of EpCAM as a molecular target of prostate cancer stroma. Am J Pathol 2009 0.91
72 Image guidance in the focal treatment of prostate cancer. Curr Opin Urol 2012 0.90
73 Active surveillance for prostate cancer: past, present and future. Curr Opin Oncol 2012 0.90
74 Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures. J Proteome Res 2009 0.90
75 Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma. Clin Cancer Res 2012 0.90
76 Multiparametric magnetic resonance imaging and image-guided biopsy to detect seminal vesicle invasion by prostate cancer. J Endourol 2014 0.89
77 Accelerated T2 mapping for characterization of prostate cancer. Magn Reson Med 2011 0.89
78 Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up. Diagn Interv Radiol 2014 0.89
79 MRI of localized prostate cancer: coming of age in the PSA era. Diagn Interv Radiol 2011 0.89
80 Non-invasive monitoring of tissue oxygenation during laparoscopic donor nephrectomy. BMC Surg 2008 0.88
81 Normal and variant arterial supply of the liver and gallbladder. Pediatr Transplant 2003 0.88
82 A possible new syndrome with growth-hormone secreting pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familial testicular germ cell malignancy: A case report. J Med Case Rep 2007 0.88
83 Accuracy analysis in MRI-guided robotic prostate biopsy. Int J Comput Assist Radiol Surg 2013 0.87
84 Optical access trocar injuries in urological laparoscopic surgery. J Urol 2003 0.87
85 Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int 2012 0.86
86 Usefulness of standardized uptake values for distinguishing adrenal glands with pheochromocytoma from normal adrenal glands by use of 6-18F-fluorodopamine PET. J Nucl Med 2007 0.86
87 Layered peptide array for multiplex immunohistochemistry. J Mol Diagn 2007 0.85
88 Imaging modalities in focal therapy: patient selection, treatment guidance, and follow-up. Curr Opin Urol 2014 0.85
89 Current status of nephron-sparing robotic partial nephrectomy. Curr Opin Urol 2010 0.85
90 Outcomes and timing for intervention of partial adrenalectomy in patients with a solitary adrenal remnant and history of bilateral phaeochromocytomas. BJU Int 2010 0.85
91 Robot-assisted laparoscopic partial adrenalectomy for pheochromocytoma: the National Cancer Institute technique. Eur Urol 2011 0.84
92 Comparison of calculated and acquired high b value diffusion-weighted imaging in prostate cancer. Abdom Imaging 2015 0.84
93 Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI. Cancer Imaging 2011 0.83
94 Partial adrenalectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von Hippel-Lindau syndrome. J Pediatr Surg 2012 0.82
95 Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer. Curr Urol Rep 2014 0.82
96 Multiparametric magnetic resonance imaging of the prostate aids detect lesion progression. J Comput Assist Tomogr 2014 0.82
97 Image-guided focal therapy for prostate cancer. Diagn Interv Radiol 2014 0.82
98 Changes observed in multiparametric prostate magnetic resonance imaging characteristics correlate with histopathological development of chronic granulomatous prostatitis after intravesical Bacillus Calmette-Guerin therapy. J Comput Assist Tomogr 2014 0.81
99 Optimizing Patient Population for MP-MRI and Fusion Biopsy for Prostate Cancer Detection. Curr Urol Rep 2015 0.81
100 Pathologic findings in patients with ureteropelvic junction obstruction and crossing vessels. Urology 2009 0.81
101 Laparoscopic renal surgery after spontaneous retroperitoneal hemorrhage. J Urol 2003 0.81
102 Characterization and management of testicular pathology in McCune-Albright syndrome. J Clin Endocrinol Metab 2012 0.80
103 Concurrent robotic partial adrenalectomy and extra-adrenal pheochromocytoma resection in a pediatric patient with von Hippel-Lindau disease. J Endourol 2008 0.80
104 Decrease in CD8+ lymphocyte number and altered cytokine profile in human prostate cancer. Am J Cancer Res 2010 0.80
105 Fully automated prostate segmentation on MRI: comparison with manual segmentation methods and specimen volumes. AJR Am J Roentgenol 2013 0.80
106 Evaluation of real-time infrared intraoperative cholangiography in a porcine model. Surg Endosc 2008 0.79
107 Laparoscopic-assisted renal autotransplantation. Urology 2004 0.79
108 Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session. Diagn Interv Radiol 2014 0.79
109 Bipolar needle electrocautery for laparoscopic partial nephrectomy without renal vascular occlusion in a porcine model. Urology 2003 0.79
110 Economic burden of repeat renal surgery on solitary kidney--do the ends justify the means? A cost analysis. J Urol 2012 0.79
111 Differentiating Transition Zone Cancers From Benign Prostatic Hyperplasia by Quantitative Multiparametric Magnetic Resonance Imaging. J Comput Assist Tomogr 2016 0.79
112 Management of obliterated urinary segments using a laser fiber for access. J Urol 2003 0.79
113 Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder. J Transl Med 2014 0.78
114 Intraoperative assessment of critical biliary structures with visible range/infrared image fusion. J Am Coll Surg 2007 0.78
115 Laparoscopic nephrectomy: assessment of morcellation versus intact specimen extraction on postoperative status. J Urol 2003 0.77
116 Lymph node staging in prostate cancer. Curr Urol Rep 2015 0.77
117 A phase I feasibility study of an intraprostatic prostate-specific antigen-based vaccine in patients with prostate cancer with local failure after radiation therapy or clinical progression on androgen-deprivation therapy in the absence of local definitive therapy. Clin Genitourin Cancer 2006 0.77
118 Radical endoscopic assisted perineal prostatectomy. J Urol 2003 0.77
119 Perioperative, functional, and oncologic outcomes of partial adrenalectomy for multiple ipsilateral pheochromocytomas. J Endourol 2013 0.77
120 MRI characterization of the dynamic effects of 5α-reductase inhibitors on prostate zonal volumes. Can J Urol 2013 0.77
121 Visual enhancement of laparoscopic partial nephrectomy with 3-charge coupled device camera: assessing intraoperative tissue perfusion and vascular anatomy by visible hemoglobin spectral response. J Urol 2010 0.76
122 The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma. J Urol 2011 0.76
123 Assessment of critical renal ischemia with real-time infrared imaging. J Surg Res 2008 0.76
124 Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer. Top Magn Reson Imaging 2016 0.76
125 Enhanced surgical imaging: laparoscopic vessel identification and assessment of tissue oxygenation. J Am Coll Surg 2008 0.76
126 Feasibility and outcomes of laparoscopic renal intervention after prior open ipsilateral retroperitoneal surgery. J Endourol 2013 0.75
127 Commentary on: "Focal cryosurgical ablation of the prostate: a single institute's perspective". BMC Urol 2013 0.75
128 Prostatic abscess in a pediatric patient with chronic granulomatous disease: report of a unique case and review of the literature. J Pediatr Surg 2012 0.75
129 Robotic nephrectomy for kidney cancer in a horseshoe kidney with renal vein tumor thrombus: novel technique for thrombectomy. J Endourol 2008 0.75
130 MRI-targeted biopsy: is systematic biopsy obsolete? Can J Urol 2017 0.75
131 Identification by digital immunohistochemistry of intratumoral changes of immune infiltrates after vaccine in the absence of modifications of PBMC immune cell subsets. Int J Cancer 2014 0.75
132 Metastatic renal cell carcinoma to contralateral ureter presenting as acute obstructive renal failure after radical nephrectomy. Urology 2005 0.75
133 Urethral stricture after pancreas-kidney transplantation due to polypoid urethritis. Urology 2004 0.75
134 18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology. Clin Nucl Med 2017 0.75
135 Laparoscopic kidney donation: looking more than skin deep. Am J Transplant 2005 0.75
136 Endourologic management of duodenal calculi in pancreas-kidney transplantation. Urol Int 2005 0.75